ARTICLE | Clinical News
Vascular Lipid Removal: LIPD began an Australian Phase I trial in 10 volunteers of its VLR human plasma delipidation system, which filters and delipidates plasm
May 13, 2002 7:00 AM UTC
Lipid Sciences Inc. (LIPD), Pleasanton, Calif. Product: Vascular Lipid Removal (VLR) system Business: Cardiovascular Therapeutic category: Blood substitute Target: Lipids Description: Technology for d...